Literature DB >> 17531143

High prevalence of human polyomavirus JC VP1 gene sequences in pediatric malignancies.

B Shiramizu1, N Hu, R J Frisque, V R Nerurkar.   

Abstract

The oncogenic potential of human polyomavirus JC (JCV), a ubiquitous virus that establishes infection during early childhood in approximately 70% of the human population, is unclear. As a neurotropic virus, JCV has been implicated in pediatric central nervous system tumors and has been suggested to be a pathogenic agent in pediatric acute lymphoblastic leukemia. Recent studies have demonstrated JCV gene sequences in pediatric medulloblastomas and among patients with colorectal cancer. JCV early protein T-antigen (TAg) can form complexes with cellular regulatory proteins and thus may play a role in tumorigenesis. Since JCV is detected in B-lymphocytes, a retrospective analysis of pediatric B-cell and non-B-cell malignancies as well as other HIV-associated pediatric malignancies was conducted for the presence of JCV gene sequences. DNA was extracted from 49 pediatric malignancies, including Hodgkin disease, non-Hodgkin lymphoma, large cell lymphoma and sarcoma. Polymerase chain reaction (PCR) was conducted using JCV specific nested primer sets for the transcriptional control region (TCR), TAg, and viral capsid protein 1 (VP1) genes. Southern blot analysis and DNA sequencing were used to confirm specificity of the amplicons. A 215-bp region of the JCV VP1 gene was amplified from 26 (53%) pediatric tumor tissues. The JCV TCR and two JCV gene regions were amplified from a leiomyosarcoma specimen from an HIV-infected patient. The leiomyosarcoma specimen from the cecum harbored the archetype strain of JCV. Including the leiomyosarcoma specimen, three of five specimens sequenced were typed as JCV genotype 2. The failure to amplify JCV TCR, and TAg gene sequences in the presence of JCV VP1 gene sequence is surprising. Even though JCV TAg gene, which is similar to the SV40 TAg gene, is oncogenic in animal models, the presence of JCV gene sequences in pediatric malignancies does not prove causality. In light of the available data on the presence of JCV in normal and cancerous colon epithelial tissue and our data on amplification of JCV from the cecum of an HIV-infected pediatric patient, further studies are warranted on the role of colon epithelium in the pathogenesis of JCV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531143      PMCID: PMC9470227     

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.206


  44 in total

1.  JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML.

Authors:  H T Agostini; C F Ryschkewitsch; R Mory; E J Singer; G L Stoner
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

2.  JC virusType 2: definition of subtypes based on DNA sequence analysis of ten complete genomes.

Authors:  H T Agostini; Y Shishido-Hara; R W Baumhefner; E J Singer; C F Ryschkewitsch; G L Stoner
Journal:  J Gen Virol       Date:  1998-05       Impact factor: 3.891

3.  Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas.

Authors:  B Krynska; L Del Valle; S Croul; J Gordon; C D Katsetos; M Carbone; A Giordano; K Khalili
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  High frequency of polyomavirus infection in lymphoid cell preparations after allogeneic bone marrow transplantation.

Authors:  E M Schneider; K Dörries
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

5.  Induction of genomic instability in SV40 transformed human cells: sufficiency of the N-terminal 147 amino acids of large T antigen and role of pRB and p53.

Authors:  C Woods; C LeFeuvre; N Stewart; S Bacchetti
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

6.  Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.

Authors:  H T Agostini; C F Ryschkewitsch; G L Stoner
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

7.  Chromosomal imbalances and DNA amplifications in SV40 large T antigen-induced primitive neuroectodermal tumor cell lines of the rat.

Authors:  R Kappler; T Pietsch; S Weggen; O D Wiestler; H Scherthan
Journal:  Carcinogenesis       Date:  1999-08       Impact factor: 4.944

8.  Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS.

Authors:  K L McClain; C T Leach; H B Jenson; V V Joshi; B H Pollock; R T Parmley; F J DiCarlo; E G Chadwick; S B Murphy
Journal:  N Engl J Med       Date:  1995-01-05       Impact factor: 91.245

9.  JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency.

Authors:  M C Monaco; W J Atwood; M Gravell; C S Tornatore; E O Major
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Survey of human polyomavirus (JCV, BKV) infections in 139 patients with lung cancer, breast cancer, melanoma, or lymphoma.

Authors:  T F Hogan; B L Padgett; D L Walker; E C Borden; Z Frias
Journal:  Prog Clin Biol Res       Date:  1983
View more
  8 in total

1.  Cross-talk between T-Ag presence and pRb family and p53/p73 signaling in mouse and human medulloblastoma.

Authors:  Valentina Caracciolo; Marcella Macaluso; Luca D'Agostino; Micaela Montanari; Jonathan Scheff; Krzysztof Reiss; Kamel Khalili; Antonio Giordano
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

2.  Alterations of the plasma membrane caused by murine polyomavirus proliferation: an electrorotation study.

Authors:  Valerio Berardi; Cecilia Aiello; Adalberto Bonincontro; Gianfranco Risuleo
Journal:  J Membr Biol       Date:  2009-05-09       Impact factor: 1.843

3.  Cognitive performance related to HIV-1-infected monocytes.

Authors:  Ian Kusao; Bruce Shiramizu; Chin-Yuan Liang; John Grove; Melissa Agsalda; David Troelstrup; Van-Nicholas Velasco; Andrew Marshall; Nicholas Whitenack; Cecilia Shikuma; Victor Valcour
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

Review 4.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 5.  JC virus: an oncogenic virus in animals and humans?

Authors:  Melissa S Maginnis; Walter J Atwood
Journal:  Semin Cancer Biol       Date:  2009-02-24       Impact factor: 15.707

6.  Urinary BK Virus Excretion in Children Newly Diagnosed with Acute Lymphoblastic Leukemia.

Authors:  Nahid Raeesi; Alaleh Gheissari; Marzieh Akrami; Sharareh Moghim
Journal:  Int J Prev Med       Date:  2012-06

7.  Childhood cancers: what is a possible role of infectious agents?

Authors:  Kenneth Alibek; Assel Mussabekova; Ainur Kakpenova; Assem Duisembekova; Yeldar Baiken; Bauyrzhan Aituov; Nargis Karatayeva; Samal Zhussupbekova
Journal:  Infect Agent Cancer       Date:  2013-12-10       Impact factor: 2.965

Review 8.  The Role of the JC Virus in Central Nervous System Tumorigenesis.

Authors:  Nicholas Ahye; Anna Bellizzi; Dana May; Hassen S Wollebo
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.